SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $3,605,000 | +8.5% | 102,889 | +2.8% | 0.00% | -20.0% |
Q4 2018 | $3,324,000 | -66.3% | 100,058 | -48.9% | 0.01% | -16.7% |
Q3 2018 | $9,862,000 | +72.4% | 195,882 | +104.9% | 0.01% | -14.3% |
Q2 2018 | $5,721,000 | +42.7% | 95,589 | +9.2% | 0.01% | +40.0% |
Q1 2018 | $4,008,000 | +14.7% | 87,513 | -0.2% | 0.01% | +25.0% |
Q4 2017 | $3,495,000 | -23.8% | 87,715 | -23.5% | 0.00% | -33.3% |
Q3 2017 | $4,586,000 | -77.2% | 114,653 | -75.4% | 0.01% | -78.6% |
Q2 2017 | $20,087,000 | +47.1% | 466,060 | +6.9% | 0.03% | +40.0% |
Q1 2017 | $13,651,000 | +26.2% | 436,121 | +1.8% | 0.02% | +17.6% |
Q4 2016 | $10,814,000 | -28.6% | 428,260 | -30.1% | 0.02% | -32.0% |
Q3 2016 | $15,145,000 | +23.0% | 612,409 | +1.3% | 0.02% | +19.0% |
Q2 2016 | $12,309,000 | +46.7% | 604,277 | +9.8% | 0.02% | +40.0% |
Q1 2016 | $8,390,000 | +23.8% | 550,195 | +9.1% | 0.02% | +15.4% |
Q4 2015 | $6,775,000 | +7.1% | 504,095 | +11.8% | 0.01% | 0.0% |
Q3 2015 | $6,328,000 | -5.4% | 451,035 | +14.5% | 0.01% | +8.3% |
Q2 2015 | $6,688,000 | +1005.5% | 393,862 | +686.7% | 0.01% | +1100.0% |
Q1 2015 | $605,000 | +45.4% | 50,065 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $416,000 | -4.4% | 50,065 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $435,000 | -20.6% | 50,065 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $548,000 | +166.0% | 50,065 | +117.6% | 0.00% | – |
Q1 2014 | $206,000 | +67.5% | 23,012 | +40.6% | 0.00% | – |
Q4 2013 | $123,000 | +2.5% | 16,372 | 0.0% | 0.00% | – |
Q3 2013 | $120,000 | +13.2% | 16,372 | -0.7% | 0.00% | – |
Q2 2013 | $106,000 | – | 16,489 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |